Navigation Links
Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma
Date:6/16/2008

Spin-out of Program Allows Verus to Focus Solely on AstraZeneca

Collaboration

SAN DIEGO, June 16 /PRNewswire/ -- Verus Pharmaceuticals, Inc., a pediatric-oriented specialty pharmaceutical company, announced today that Meritage Pharma, Inc., a newly formed specialty pharmaceutical company, has acquired its pediatric gastrointestinal development program. Included in the transaction are the rights to a novel formulation of an existing molecule intended to treat an emerging allergic inflammation condition of the gastrointestinal tract.

Under the terms of the agreement, Verus is to receive an upfront payment and will retain a minority equity stake in the newly formed company. No further terms have been disclosed. Selected members of the existing Verus management team will form the management team at Meritage Pharma.

"We are excited to have completed this transaction with Meritage Pharma, a company with an extensive knowledge of the development program and a strong management team," said Robert W. Keith, President and Chief Executive Officer of Verus. "This transaction, in combination with the recent divestiture of our anaphylaxis franchise to Sciele, allows us to focus all of our efforts on the successful execution of our ongoing asthma development collaboration with AstraZeneca and the associated $280 million potential earn-out payment."

"Meritage Pharma is proud to acquire this exciting development program as our initial product candidate and is eager to leverage the prior efforts of Verus to address an emerging condition," said Dr. Elaine M. Phillips, President and Chief Executive Officer of Meritage Pharma.

About Verus

Verus Pharmaceuticals is dedicated to improving the lives of children and those who care for them. Verus is building a portfolio of products for the unmet medical needs of children through acquisitions and alliances, with an initial focus on the treatment of asthma, all
'/>"/>

SOURCE Verus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk
2. ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio
3. Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
6. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
7. Jazz Pharmaceuticals Announces Development Timeline Updates
8. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
9. Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent
10. Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
11. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... AngelWeddingDress is now providing worldwide clients ... collections ”. When it comes to buying summer wedding ... with the unlimited stock of beautiful wedding gowns. Recently, ... wonderful summer wedding gowns. , The company’s current ... keep pace with the newest fashion trends. The top ...
(Date:7/11/2014)... July 11, 2014 Shoulder instability is ... of return to play has not been regularly determined ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Annual ... is approximately 90 percent no matter what the stabilization ... success rate of return to play following shoulder stabilization ...
(Date:7/11/2014)... SEATTLE, WA Re-tearing a repaired knee Anterior Cruciate ... study being presented today at the American Orthopaedic Society ... and patient education regarding modifiable risk factors may minimize ... "Our research suggests that a few risk factors such ... may point to the possibility of re-injury," said lead ...
(Date:7/11/2014)... Austin, TX (PRWEB) July 11, 2014 ... with their customers and to show more about their ... http://www.kennrenner.com/buyaveryranch/ and view their home videos online, ... , Avery Ranch is Austin, Texas’ premiere golf course ... the city limits of Austin. Avery Ranch features an ...
(Date:7/11/2014)... Wearing the school motto on their shirts, ... staff came together this past Saturday morning ready to wave, ... the Homer Township Independence Day Parade. The theme of ... , Everest community recognized the theme of A Salute ... and blue. The blue Everest balloons filled with helium ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients 2Health News:Stabilizing Shoulder Surgery Helps NFL Players Return to the Game 2Health News:Avery Ranch Announces Their New Website to Better Connect with Customers 2Health News:Everest Academy Participates in the Homer Township Independence Day Parade 2
... (OTC,Bulletin Board: CHRX, CHRXU, CHRXW), a leading provider of ... has,changed to CHRX from PMQC. The Company,s common stock ... About Chem Rx Corporation, Founded more than ... of institutional pharmacy services in the New York City,metropolitan ...
... monitor/defibrillators help ensure safety at 112th ... Royal Philips,Electronics (NYSE: PHG , AEX: PHI) ... automated external defibrillators (AEDs) and advanced life,support (ALS) ... run on April 21. The strategic deployment of ...
... 18 Ferring Pharmaceuticals Inc.,has announced that its ... serve as the sponsor for masters track club,Sprint ... commitment to active aging," said,Alex Drigan, Product Director, ... of track and believe that they can inspire ...
... April 18 Chronic pain in the ball ... Metatarsalgia ( http://www.OurHealthNetwork.com/metatarsalgia ) is a,catch-all term ... dropped metatarsal heads, bursitis, arthritis, sesamoiditis, and,Morton,s neuroma. ... each step for them a nightmare., When ...
... density affects memory and psychomotor speed, study says , , ... solvents in products such as paints and dry cleaning ... report. , These abnormalities play a role in ... team conclude in the April issue of the ...
... PROTECTION IN A SUNSCREEN WITH ... MEXORYL(TM) SX, ... worldwide, announces the FDA approval,of ANTHELIOS 40 with the highest photostable UVA ... is a,revolutionary outdoor use sunscreen for the face and body, specifically,tested for ...
Cached Medicine News:Health News:Chem Rx Corporation Changes Ticker Symbol to CHRX 2Health News:Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices 2Health News:Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices 3Health News:Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices 4Health News:Ferring Pharmaceuticals' EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club 2Health News:Ferring Pharmaceuticals' EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club 3Health News:Metatarsalgia (or Forefoot Pain) Affects Millions of Americans; Podiatrists Discuss How to Relieve Metatarsalgia Pain 2Health News:Chronic Exposure to Solvents Disturbs Brain's Wiring 2Health News:ANTHELIOS 40 Sunscreen with Mexoryl(TM) SX From the brand trusted for over 15 years worldwide to offer high UVA protection 2Health News:ANTHELIOS 40 Sunscreen with Mexoryl(TM) SX From the brand trusted for over 15 years worldwide to offer high UVA protection 3Health News:ANTHELIOS 40 Sunscreen with Mexoryl(TM) SX From the brand trusted for over 15 years worldwide to offer high UVA protection 4
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/10/2014)... India , July 11, 2014  Major ... treatment of cancer are being highlighted in a ... Mumbai from 10-12 July, 2014.  Renowned national ... to share best practices and exchange knowledge on ... precise, accurate and efficient. The ...
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... AVIV, Israel, May 6 InspireMD, developers of,MGuard(TM), announced ... the,iMOS registry. MGuard(TM) was successfully implanted at the General,University ... Jan Horak. , InspireMD plans ... is a post market study, will be conducted in ...
... - Conference Call Today at 5:00 p.m. Eastern Time ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... the first quarter ended March 31, 2009, and provided ... pivotal Phase 3 SPEAR trial of picoplatin for the ...
Cached Medicine Technology:InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 9
Inquire...
... Designed for the elegant and ... Avenue collection includes ophthalmic and ... in a variety of shapes ... many face shapes and complexions. ...
... updated styling through the use of innovative ... collection is for the value driven consumer ... Eyewear Collection , The futuristic quality ... of the "strongest and lightest metal on ...
Inquire...
Medicine Products: